Futu News, June 19, this Monday $ADICON HOLDINGS (09860.HK)$An announcement was announced that it will issue 33.192,500 shares from June 19 to June 23, 2023. The company plans to issue 33.25 million shares, including a public sale of 3.32 million shares (10%) and an international sale of 298.725 million shares (90%) at an offering price of HK$12.32 per share, 500 shares per lot. The shares are expected to be listed on June 30, 2023.
Company Overview
Addicon Holdings is one of China's top three independent medical laboratory (or ICL) service providers. It mainly provides rich and first-class testing services to hospitals and physical examination centers through an integrated network of 33 self-operated laboratories across the country. As of December 31, 2022, the company has 18 laboratories certified by ISO15189 to ensure that customers are provided with quality assurance that they comply with this strict international standard.
Adikon Holdings' testing portfolio includes more than 4,000 medical diagnostic tests, including more than 1,700 screening tests and more than 2,300 special tests. During the track record period, the company's number of tests increased from 60.1 million in 2020 to 165 million tests in 2022, with a compound annual growth rate of 65.6%.
Thanks to a series of favorable government policies and good trends in the industry, China's ICL market has grown rapidly in recent years. According to Frost & Sullivan's data, domestic ICL market regulations...